The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Changing landscape of cannabis: novel products, formulations, and methods of administration
Open accessAbstract
Laws regulating cannabis have changed radically in the U.S. and abroad. Historically, users smoked dried cannabis flowers that contained Δ9-tetrahydrocannabinol (THC), the primary psychoactive component of cannabis, as the principal product constituent. Coincident with cannabis legalization and increased interest in medicinal use of the plant, there is now an expansive retail cannabis marketplace with novel cannabis products, formulations, and methods of administration. In this review, we describe emergent cannabis product chemotypes (e.g. THC-dominant, CBD-dominant, balanced or ‘hybrid’ with high concentrations of THC and CBD), product formulations (e.g. edibles, concentrates), and methods of administration (e.g. smoked, vaporized, orally ingested). Psychologists can play a pivotal role in studying the health impact of cannabis legalization and conducting research to inform product regulation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome
Devinsky, O., Cross, J. H., Laux, L., Marsh, E., Miller, I., Nabbout, R., Scheffer, I. E., Thiele, E. A., & Wright, S. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1611618 · Cited by 1,711
Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects.
Russo, E. B. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01238.x · Cited by 1,535
Human Cannabinoid Pharmacokinetics
Huestis, M. A. (2007) · Chemistry & Biodiversity · doi:10.1002/cbdv.200790152 · Cited by 1,102
Prevalence of marijuana use disorders in the United States between 2001-2002 and 2012-2013.
Hasin, D. S., Saha, T. D., Kerridge, B. T., Goldstein, R. B., Chou, S. P., Zhang, H., Jung, J., Pickering, R. P., Ruan, W. J., Smith, S. M., et al. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2015.1858 · Cited by 1,086
ElSohly, M. A., Mehmedic, Z., Foster, S., Gon, C., Chandra, S., & Church, J. C. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.01.004 · Cited by 995
Cannabidiol as a Potential Treatment for Anxiety Disorders
Blessing, E. M., Steenkamp, M. M., Manzanares, J., & Marmar, C. R. (2015) · Neurotherapeutics · doi:10.1007/s13311-015-0387-1 · Cited by 695
Cannabis use, attitudes, and legal status in the U.S.: A review
Carliner, H., Brown, Q. L., Sarvet, A. L., & Hasin, D. S. (2017) · Preventive Medicine · doi:10.1016/j.ypmed.2017.07.008 · Cited by 545
Labeling Accuracy of Cannabidiol Extracts Sold Online
Bonn-Miller, M. O., Loflin, M. J. E., Thomas, B. F., Marcu, J. P., Hyke, T., & Vandrey, R. (2017) · JAMA · doi:10.1001/jama.2017.11909 · Cited by 529
Self-citationCannabinoid Dose and Label Accuracy in Edible Medical Cannabis Products
Vandrey, R., Raber, J. C., Raber, M. E., Douglass, B., Miller, C., & Bonn-Miller, M. O. (2015) · JAMA · doi:10.1001/jama.2015.6613 · Cited by 367
Self-citationSex Differences in Cannabis Use and Effects: A Cross-Sectional Survey of Cannabis Users
Cuttler, C., Mischley, L. K., & Sexton, M. (2016) · Cannabis and Cannabinoid Research · doi:10.1089/can.2016.0010 · Cited by 349
Toking, Vaping, and Eating for Health or Fun
Schauer, G. L., King, B. A., Bunnell, R. E., Promoff, G., & McAfee, T. A. (2016) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2015.05.027 · Cited by 344
Berg, C. J., Stratton, E., Schauer, G. L., Lewis, M., Wang, Y., Windle, M., & Kegler, M. (2015) · Substance Use & Misuse · doi:10.3109/10826084.2014.958857 · Cited by 338
Industrial Hemp in North America: Production, Politics and Potential
Cherney, J., & Small, E. (2016) · Agronomy · doi:10.3390/agronomy6040058 · Cited by 328
Russell, C., Rueda, S., Room, R., Tyndall, M., & Fischer, B. (2018) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2017.11.008 · Cited by 298
Spindle, T. R., Cone, E. J., Schlienz, N. J., Mitchell, J. M., Bigelow, G. E., Flegel, R., Hayes, E., & Vandrey, R. (2018) · JAMA Network Open · doi:10.1001/jamanetworkopen.2018.4841 · Cited by 265
Self-citationMedical cannabis and mental health: A guided systematic review
Walsh, Z., Gonzalez, R., Crosby, K., S. Thiessen, M., Carroll, C., & Bonn-Miller, M. O. (2017) · Clinical Psychology Review · doi:10.1016/j.cpr.2016.10.002 · Cited by 244
Self-citationSmoking, vaping, eating: Is legalization impacting the way people use cannabis?
Borodovsky, J. T., Crosier, B. S., Lee, D. C., Sargent, J. D., & Budney, A. J. (2016) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2016.02.022 · Cited by 237
Vandrey, R., Herrmann, E. S., Mitchell, J. M., Bigelow, G. E., Flegel, R., LoDico, C., & Cone, E. J. (2017) · Journal of Analytical Toxicology · doi:10.1093/jat/bkx012 · Cited by 215
Self-citationHaney, M., Malcolm, R. J., Babalonis, S., Nuzzo, P. A., Cooper, Z. D., Bedi, G., Gray, K. M., McRae-Clark, A., Lofwall, M. R., Sparenborg, S., et al. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2015.367 · Cited by 206
Klein, C., Karanges, E., Spiro, A., Wong, A., Spencer, J., Huynh, T., Gunasekaran, N., Karl, T., Long, L. E., Huang, X.-F., et al. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2342-0 · Cited by 206
Raber, J. C., Elzinga, S., & Kaplan, C. (2015) · The Journal of Toxicological Sciences · doi:10.2131/jts.40.797 · Cited by 206
Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome
(2017) · New England Journal of Medicine · doi:10.1056/nejmc1708349 · Cited by 206
A new method of cannabis ingestion: The dangers of dabs?
Loflin, M., & Earleywine, M. (2014) · Addictive Behaviors · doi:10.1016/j.addbeh.2014.05.013 · Cited by 205
Review of the neurological benefits of phytocannabinoids
Maroon, J., & Bost, J. (2018) · Surgical Neurology International · doi:10.4103/sni.sni_45_18 · Cited by 203
Tasty THC: Promises and Challenges of Cannabis Edibles
International, R., Barrus, D., Capogrossi, K., Cates, S., Gourdet, C., Peiper, N., Novak, S., Lefever, T., & Wiley, J. (2016) · doi:10.3768/rtipress.2016.op.0035.1611 · Cited by 194
Emerging Trends in Cannabis Administration Among Adolescent Cannabis Users
Knapp, A. A., Lee, D. C., Borodovsky, J. T., Auty, S. G., Gabrielli, J., & Budney, A. J. (2019) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2018.07.012 · Cited by 179
Cannabis: From Cultivar to Chemovar II—A Metabolomics Approach to Cannabis Classification
Hazekamp, A., Tejkalová, K., & Papadimitriou, S. (2016) · Cannabis and Cannabinoid Research · doi:10.1089/can.2016.0017 · Cited by 177
Haug, N. A., Padula, C. B., Sottile, J. E., Vandrey, R., Heinz, A. J., & Bonn-Miller, M. O. (2017) · Addictive Behaviors · doi:10.1016/j.addbeh.2017.03.006 · Cited by 165
Self-citationNeurophysiological and subjective profile of marijuana with varying concentrations of cannabinoids
Ilan, A. B., Gevins, A., Coleman, M., ElSohly, M. A., & de Wit, H. (2005) · Behavioural Pharmacology · doi:10.1097/00008877-200509000-00023 · Cited by 163
U.S. cannabis legalization and use of vaping and edible products among youth
Borodovsky, J. T., Lee, D. C., Crosier, B. S., Gabrielli, J., Sargent, J. D., & Budney, A. J. (2017) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2017.02.017 · Cited by 155
Online survey characterizing vaporizer use among cannabis users
Lee, D. C., Crosier, B. S., Borodovsky, J. T., Sargent, J. D., & Budney, A. J. (2015) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2015.12.020 · Cited by 146
Smoking, Vaping, and Use of Edibles and Other Forms of Marijuana Among U.S. Adults
Steigerwald, S., Wong, P. O., Cohen, B. E., Ishida, J. H., Vali, M., Madden, E., & Keyhani, S. (2018) · Annals of Internal Medicine · doi:10.7326/m18-1681 · Cited by 146
Cannabis Oil: chemical evaluation of an upcoming cannabis-based medicine
Romano, L. L., & Hazekamp, A. (2013) · Cited by 129
van der Pol, P., Liebregts, N., Brunt, T. M., van Amsterdam, J., de Graaf, R., Korf, D. J., van den Brink, W., & van Laar, M. (2014) · Addiction · doi:10.1111/add.12508 · Cited by 123
Gieringer, D. H., Laurent, J. S., & Goodrich, S. (2004) · Journal of Cannabis Therapeutics · doi:10.1300/j175v04n01_02 · Cited by 121
“Those edibles hit hard”: Exploration of Twitter data on cannabis edibles in the U.S
Lamy, F. R., Daniulaityte, R., Sheth, A., Nahhas, R. W., Martins, S. S., Boyer, E. W., & Carlson, R. G. (2016) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2016.04.029 · Cited by 120
Schwope, D. M., Bosker, W. M., Ramaekers, J. G., Gorelick, D. A., & Huestis, M. A. (2012) · Journal of Analytical Toxicology · doi:10.1093/jat/bks044 · Cited by 108
Predictors of Adult E-Cigarette Users Vaporizing Cannabis Using E-Cigarettes and Vape-Pens
Morean, M. E., Lipshie, N., Josephson, M., & Foster, D. W. (2017) · Substance Use & Misuse · doi:10.1080/10826084.2016.1268162 · Cited by 100
Associations between butane hash oil use and cannabis-related problems
Meier, M. H. (2017) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2017.06.015 · Cited by 94
Newmeyer, M. N., Swortwood, M. J., Abulseoud, O. A., & Huestis, M. A. (2017) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2017.02.003 · Cited by 92
Edible Cannabis–Induced Psychosis: Intoxication and Beyond
Hudak, M., Severn, D. G., & Nordstrom, K. (2015) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2015.15030358 · Cited by 88
Lankenau, S. E., Fedorova, E. V., Reed, M. K., Schrager, S. M., Iverson, E., & Wong, C. F. (2016) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2016.10.025 · Cited by 73
Characterizing marijuana concentrate users: A web-based survey
Daniulaityte, R., Lamy, F. R., Barratt, M. J., Nahhas, R. W., Martins, S. S., Boyer, E. W., Sheth, A., & Carlson, R. G. (2017) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2017.05.034 · Cited by 66
The Form and Content of Cannabis Products in the United States
Steigerwald, S., Wong, P. O., Khorasani, A., & Keyhani, S. (2018) · Journal of General Internal Medicine · doi:10.1007/s11606-018-4480-0 · Cited by 66
A content analysis of tweets about high-potency marijuana
Cavazos‐Rehg, P. A., Sowles, S. J., Krauss, M. J., Agbonavbare, V., Grucza, R. A., & Bierut, L. J. (2016) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2016.06.034 · Cited by 63
Sexton, M., Shelton, K., Haley, P., & West, M. (2018) · Planta Medica · doi:10.1055/s-0043-119361 · Cited by 59
Cranford, J. A., Bohnert, K. M., Perron, B. E., Bourque, C. A., & Ilgen, M. A. (2016) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2016.10.008 · Cited by 45
Loflin, M., & Earleywine, M. (2015) · Europe PMC (PubMed Central) · Cited by 32
Lamy, F. R., Daniulaityte, R., Zatreh, M. Y., Nahhas, R. W., Sheth, A., Martins, S. S., Boyer, E. W., & Carlson, R. G. (2017) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2017.10.039 · Cited by 29
Cited by
Assessing the public health impacts of legalizing recreational cannabis use: the US experience
Hall, W., & Lynskey, M. (2020) · World Psychiatry · doi:10.1002/wps.20735 · Cited by 296
Fischer, B., Robinson, T., Bullen, C., Curran, V., Jutras-Aswad, D., Medina-Mora, M. E., Pacula, R. L., Rehm, J., Room, R., Brink, W. V. D., et al. (2022) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2021.103381 · Cited by 236
An overview of select cannabis use and supply indicators pre- and post-legalization in Canada
Fischer, B., Lee, A., Robinson, T., & Hall, W. (2021) · Substance Abuse Treatment, Prevention, and Policy · doi:10.1186/s13011-021-00405-7 · Cited by 52
Hasin, D., Shmulewitz, D., Stohl, M., Greenstein, E., Roncone, S., Aharonovich, E., & Wall, M. (2020) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2020.108294 · Cited by 31
Athanassiou, M., Dumais, A., Gnanhoue, G., Abdel-Baki, A., Jutras-Aswad, D., & Potvin, S. (2021) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2021.1942845 · Cited by 29
Metadata
- Authors
- Spindle, T. R., Bonn-Miller, M. O., & Vandrey, R.
- Venue
- Current Opinion in Psychology
- Publisher
- Elsevier BV
- Published
- 2019-12
- Volume
- 30
- Pages
- 98-102
- ISSN
- 2352-250X (ISSN-L)
- OpenAlex
- W2947588935
- Cited by
- 259
- References
- 49
- FWCI
- 5.29
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.